 |
Related Articles |
StatPearls
Book. 2020 01
Authors:
Abstract
Amphetamine is FDA-approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. It has indications as a first-line agent for ADHD in adults and children six years of age and older. Amphetamine is also a second-line agent for the treatment of narcolepsy. Lisdexamfetamine, a long-acting amphetamine medication, is FDA-approved for the treatment of a binge-eating disorder.
PMID: 32310563
via https://www.ncbi.nlm.nih.gov/pubmed/32310563?dopt=Abstract